Simulations Plus Inc (SLP)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Simulations Plus Inc (SLP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011937
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Simulations Plus Inc (Simulations Plus) develops and markets software for drug discovery and development for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity modeling and simulation software. It provides preclinical and clinical pharmacometric consulting services to help its customers with regulatory submissions. Simulations Plus’s pharmaceutical and chemistry software is licensed to agrochemical, biotechnology, pharmaceutical and food industries, and regulatory agencies worldwide. The company offers training workshops and provides consulting services. Simulations Plus distributes its products and offers services in Australia, China, Europe, India, Japan, North America, New Zealand, South America, Singapore, and Taiwan. It operates along with its wholly owned subsidiary Cognigen Corporation. Simulations Plus is headquartered in Lancaster, California, the US.

Simulations Plus Inc (SLP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Simulations Plus Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Simulations Plus Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Simulations Plus Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Simulations Plus Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Simulations Plus Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Simulations Plus Inc, Medical Equipment, Deal Details 11
Partnerships 11
Simulations Plus Enters Into Distribution Agreement With Research Institute for Liver Diseases 11
Simulations Plus Enters Into Agreement With Pharma Company 12
Acquisition 13
Prentke Romich Completes Acquisition Of Words+ From Simulations Plus For US$2 Million 13
Simulations Plus Inc – Key Competitors 15
Simulations Plus Inc – Key Employees 16
Simulations Plus Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 14, 2017: Simulations Plus Reports FY2017 and Fourth Quarter FY2017 Financial Results 18
Oct 03, 2017: Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2017 19
Jul 10, 2017: Simulations Plus Reports Third Quarter FY2017 Financial Results 20
Jun 15, 2017: Simulations Plus Reports Record Preliminary Revenues for Third Quarter FY2017 21
Apr 10, 2017: Simulations Plus Reports Second Quarter FY2017 Financial Results 22
Mar 13, 2017: Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2017 23
Jan 09, 2017: Simulations Plus Reports First Quarter FY2017 Financial Results 24
Dec 08, 2016: Simulations Plus Reports Record Preliminary Revenues for First Quarter FY2017 25
Nov 11, 2016: Simulations Plus Reports FY2016 and Fourth Quarter FY2016 Financial Results 26
Sep 12, 2016: Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2016 27
Jul 14, 2016: Simulations Plus Reports Third Quarter FY2016 Financial Results 28
Jun 07, 2016: Simulations Plus Reports Preliminary Revenues for Third Quarter FY2016 29
Apr 13, 2016: Simulations Plus Reports Second Quarter FY2016 Financial Results 30
Mar 10, 2016: Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2016 31
Jan 14, 2016: Simulations Plus Reports First Quarter FY2016 Financial Results 32
Corporate Communications 33
Aug 31, 2017: Simulations Plus Announces Senior Management Changes 33
Product News 34
Apr 05, 2017: Simulations Plus Releases GastroPlus Version 9.5 34
Jan 12, 2017: Simulations Plus Releases ADMET Predictor Version 8.1 35
Apr 14, 2016: Simulations Plus Releases DDDPlus Version 5.0 36
Mar 15, 2016: Simulations Plus Releases KIWI Version 1.5 37
Other Significant Developments 38
Aug 23, 2017: Simulations Plus Releases MembranePlus Version 2 38
Apr 20, 2017: Simulations Plus Establishes Distribution Channel in India with Electrolab 39
Apr 06, 2017: Simulations Plus Finalizes Distributor Agreement With Korean Company 40
Sep 26, 2016: Simulations Plus Joins European SimInhale Consortium 41
Apr 06, 2016: Simulations Plus Signs 5-year Consulting Agreement with Major Research Foundation 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Simulations Plus Inc, Medical Equipment, Key Facts, 2016 2
Simulations Plus Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Simulations Plus Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Simulations Plus Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Simulations Plus Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Simulations Plus Inc, Deals By Market, 2011 to YTD 2017 9
Simulations Plus Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Simulations Plus Enters Into Distribution Agreement With Research Institute for Liver Diseases 11
Simulations Plus Enters Into Agreement With Pharma Company 12
Prentke Romich Completes Acquisition Of Words+ From Simulations Plus For US$2 Million 13
Simulations Plus Inc, Key Competitors 15
Simulations Plus Inc, Key Employees 16
Simulations Plus Inc, Other Locations 17
Simulations Plus Inc, Subsidiaries 17

★海外企業調査レポート[Simulations Plus Inc (SLP)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Factory Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Factory Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Factory Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Orchid Pharma Ltd (ORCHIDPHAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, an …
  • Asahi Intecc Co Ltd (7747):企業の財務・戦略的SWOT分析
    Summary Asahi Intecc Co Ltd (Asahi) is a medical device company that develops, manufactures and markets terminal processed products. The company provides medical components such as guide wires, balloon catheters, guiding catheters, penetration catheters, peripheral guide wires, IVR guide wires and m …
  • Parkland Fuel Corporation (PKI):石油・ガス:M&Aディール及び事業提携情報
    Summary Parkland Fuel Corp (Parkland) is a downstream energy company. It markets various fuel and petroleum products, including gasoline, propane, lubricants, diesel, heating oil, and other petroleum products. The company maintains a portfolio of supply relationships, storage infrastructure, and thi …
  • ONGC Videsh Ltd:企業の戦略的SWOT分析
    ONGC Videsh Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Sopharma AD (3JR):製薬・医療:M&Aディール及び事業提携情報
    Summary Sopharma AD (Sopharma) develops, manufactures and commercializes medicinal substances and finished dosage forms. The company focuses on the production of pharmaceutical products; substances and preparations; veterinary vaccines; infusion solutions; hemodialysis concentrates; medical disposab …
  • ARMZ Uranium Holding Co:企業の戦略的SWOT分析
    ARMZ Uranium Holding Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • SKYCITY Entertainment Group Ltd:企業の戦略・SWOT・財務情報
    SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Intercept Pharmaceuticals Inc (ICPT):企業の財務・戦略的SWOT分析
    Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lincoln Electric Holdings Inc:企業の戦略・SWOT・財務分析
    Lincoln Electric Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Lincoln Electric Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Stealth BioTherapeutics Corp (MITO):企業の戦略的SWOT分析
    Stealth BioTherapeutics Corp (MITO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cryosite Ltd (CTE):企業の財務・戦略的SWOT分析
    Summary Cryosite Ltd (Cryosite) is a healthcare solution provider that offers clinical trials outsourced logistics services to research, medical, pharmaceutical, veterinary and biotechnology industries. The company manufactures stem cell products for both therapeutic use and clinical trials. It prov …
  • Lego AS:企業の戦略的SWOT分析
    Lego AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • U.S. Stem Cell Inc (USRM):製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …
  • Koch Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Koch Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Koch Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mauna Kea Technologies SAS (MKEA)-医療機器分野:企業M&A・提携分析
    Summary Mauna Kea Technologies SAS (MKT) is a medical device company that develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. The company’s product includes cellvizio. Its cellvizio is an endomicroscopy platform that provides micr …
  • KemPharm Inc (KMPH):製薬・医療:M&Aディール及び事業提携情報
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, methylphenidate drug for ADHD; KP201/IR, KP511/ER, KP606/IR and KP746 drugs for the …
  • OHB System AG:企業の戦略・SWOT・財務情報
    OHB System AG - Strategy, SWOT and Corporate Finance Report Summary OHB System AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Citigroup Inc:企業のM&A・事業提携・投資動向
    Citigroup Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Citigroup Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆